Back to search

Article

Liraglutide and the Management of Overweight and Obesity in People with Severe Mental Illness: Qualitative Sub-Study

2021-09-20

Abstract excerpt

<h4>Background: </h4> People with severe mental illness are two to three times more likely to be overweight or have obesity than the general population and this is associated with significant morbidity and premature mortality. Liraglutide 3mg is a once daily injectable GLP-1 receptor agonist that is licensed for the treatment of obesity in the general population and has the potential to be used in people with seve...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
80ecb122-fc27-521c-97f7-56f07cfa6ed9
DOI
10.21203/rs.3.rs-763259/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Liraglutide and the Management of Overweight and Obesity in People with Severe Mental Illness: Qualitative Sub-StudyDOI 10.21203/rs.3.rs-763259/v1
Clinical assessment of liraglutide use in prediabetic and obese schizophrenic patients: A systematic literature review and meta-analysisSemantic proximity
Waist-Height ratio Highlights Detrimental Risk for Olanzapine Associated Weight Gain Earlier than Body Mass Index.Semantic proximity
Exploring the off-Label use of liraglutide in the treatment of obesity: a reviewSemantic proximity
Obesity - an epidemic of the twenty-first century: an update for psychiatrists.Semantic proximity
Effectiveness of a Pragmatic Metabolic Care Clinic for Patients with Severe Mental Illness: Protocol for the Randomized Controlled Meta-Care TrialSemantic proximity
Highway to the danger zone? A cautionary account that GLP-1 receptor agonists may be too effective for unmonitored weight lossSemantic proximity
Does Sex affect Antipsychotic Associated Weight Gain in Patients Being Treated for Psychotic Disorders: A Protocol for a Systematic ReviewSemantic proximity
Investigating the orexigenic potential of olanzapine in cancer patients (OLANZAPRIZ): A Systematic ReviewSemantic proximity
Strategic Timing of Resistance Training to Guard Against Antipsychotic-Induced Metabolic Syndrome (START GAAIMS): A Feasibility Study ProtocolSemantic proximity
Impact of Glucagon-like Peptide-1 Receptor Agonists on Mental Illness: Evidence from a Mendelian Randomization StudySemantic proximity
Real feelings and experiences of obesity patients in metabolic surgery of weight loss in Shandong,China: A qualitative researchSemantic proximity
Beyond the Checklist: A large-scale analysis of under-recognised weight loss behaviours in individuals with eating disordersSemantic proximity
Select a neighboring publication to make it the new centre.